首页 > 最新文献

Mayo Clinic proceedings最新文献

英文 中文
Building Artificial Intelligence and Data Literacy Across the Health Care Research Workforce in the Mayo Clinic Center for Clinical and Translational Science: Why It Matters and What We Are Doing About It 在梅奥临床和转化科学中心的医疗保健研究人员中建立人工智能和数据素养:为什么它很重要以及我们正在做些什么
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.11.008
Jaleh Zand PhD , Milovan Suvakov PhD , Shauna M. Overgaard PhD , Chester G. Kozikowski MEd , Ryan C. Jimison MEd , Kristina B. Nelson MS , Carmen J. Silvano , Laura M. Meiners MBA , Jungwei W. Fan PhD , Kate E. Schultz PhD , Rickey E. Carter PhD , Mark L. Wieland MD, MPH , Christi A. Patten PhD , Sagar B. Dugani MD, PhD, MPH , Jenny A. Weis MAN , John D. Poe MBA , David R. Holmes III PhD , Leigh G. Griffiths MRCVS, PhD , Heidi L. Dieter MBA , Young J. Juhn MD, MPH , Vesna D. Garovic MD, PhD
{"title":"Building Artificial Intelligence and Data Literacy Across the Health Care Research Workforce in the Mayo Clinic Center for Clinical and Translational Science: Why It Matters and What We Are Doing About It","authors":"Jaleh Zand PhD , Milovan Suvakov PhD , Shauna M. Overgaard PhD , Chester G. Kozikowski MEd , Ryan C. Jimison MEd , Kristina B. Nelson MS , Carmen J. Silvano , Laura M. Meiners MBA , Jungwei W. Fan PhD , Kate E. Schultz PhD , Rickey E. Carter PhD , Mark L. Wieland MD, MPH , Christi A. Patten PhD , Sagar B. Dugani MD, PhD, MPH , Jenny A. Weis MAN , John D. Poe MBA , David R. Holmes III PhD , Leigh G. Griffiths MRCVS, PhD , Heidi L. Dieter MBA , Young J. Juhn MD, MPH , Vesna D. Garovic MD, PhD","doi":"10.1016/j.mayocp.2025.11.008","DOIUrl":"10.1016/j.mayocp.2025.11.008","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 17-25"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mayo Clinic Proceedings and Evolution of Diabetes Management: A Century of Companionship 梅奥诊所程序和糖尿病管理的演变:一个世纪的陪伴
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.11.007
Vinaya Simha MD
{"title":"Mayo Clinic Proceedings and Evolution of Diabetes Management: A Century of Companionship","authors":"Vinaya Simha MD","doi":"10.1016/j.mayocp.2025.11.007","DOIUrl":"10.1016/j.mayocp.2025.11.007","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 4-6"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Educating Health Care Professionals About Artificial Intelligence 对医疗保健专业人员进行人工智能教育
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.11.010
Karl A. Nath MBChB (Editor-in-Chief)
{"title":"Educating Health Care Professionals About Artificial Intelligence","authors":"Karl A. Nath MBChB (Editor-in-Chief)","doi":"10.1016/j.mayocp.2025.11.010","DOIUrl":"10.1016/j.mayocp.2025.11.010","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 7-11"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retirement: Fostering Physician Well-being Over the Career Life Cycle 退休:在职业生命周期中培养医生的幸福感。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.05.027
Kirk J. Brower MD , Iris F. Litt MD , Tait D. Shanafelt MD
This manuscript is the last chapter in a series of 5 articles considering physician well-being during the course of a career. It focuses on the retirement stage, which follows planning for retirement and deciding when and how to retire. We view retirement as a process, characterized by recalibrating professional and personal activities while maintaining a sense of purpose and meaning in life. Some retirees may continue to work in medicine by seeing patients part-time or mentoring medical students, residents, and junior colleagues. Others may leave their lifelong work and seek joy and meaning in travel, spending time with family and friends, volunteering, and developing their personal interests and activities. Ideally, well-being in retirement includes having sufficient energy for activities and relationships that are meaningful, provide purpose, and are enjoyable. Stress during retirement usually shifts from occupational concerns to personal challenges with professional identity, caring for family and friends, maintaining one’s health, and relationship losses. Programs that specifically support retired physicians exist at some large health systems and select academic centers, which can complement resources provided by general medical associations and specialty societies. These can serve as models for other medical centers and a foundation for extending and expanding support to retired physicians.
这份手稿是在一系列的5篇文章的最后一章考虑医生的福祉在职业生涯的过程中。它侧重于退休阶段,这是继退休计划和决定何时以及如何退休之后的阶段。我们认为退休是一个过程,其特点是重新调整职业和个人活动,同时保持生活的使命感和意义。一些退休人员可能会继续从事医学工作,兼职看病或指导医学生、住院医生和初级同事。其他人可能会离开他们的终身工作,在旅行中寻找快乐和意义,与家人和朋友共度时光,做志愿者,发展他们的个人兴趣和活动。理想情况下,退休后的幸福生活包括有足够的精力从事有意义的、有目的的、令人愉快的活动和人际关系。退休期间的压力通常从职业问题转移到个人挑战,包括职业身份、照顾家人和朋友、保持健康和失去关系。一些大型医疗系统和一些学术中心都有专门支持退休医生的项目,这些项目可以补充普通医学协会和专业协会提供的资源。这可以作为其他医疗中心的榜样,并为扩大和扩大对退休医生的支持奠定基础。
{"title":"Retirement: Fostering Physician Well-being Over the Career Life Cycle","authors":"Kirk J. Brower MD ,&nbsp;Iris F. Litt MD ,&nbsp;Tait D. Shanafelt MD","doi":"10.1016/j.mayocp.2025.05.027","DOIUrl":"10.1016/j.mayocp.2025.05.027","url":null,"abstract":"<div><div>This manuscript is the last chapter in a series of 5 articles considering physician well-being during the course of a career. It focuses on the retirement stage, which follows planning for retirement and deciding when and how to retire. We view retirement as a process, characterized by recalibrating professional and personal activities while maintaining a sense of purpose and meaning in life. Some retirees may continue to work in medicine by seeing patients part-time or mentoring medical students, residents, and junior colleagues. Others may leave their lifelong work and seek joy and meaning in travel, spending time with family and friends, volunteering, and developing their personal interests and activities. Ideally, well-being in retirement includes having sufficient energy for activities and relationships that are meaningful, provide purpose, and are enjoyable. Stress during retirement usually shifts from occupational concerns to personal challenges with professional identity, caring for family and friends, maintaining one’s health, and relationship losses. Programs that specifically support retired physicians exist at some large health systems and select academic centers, which can complement resources provided by general medical associations and specialty societies. These can serve as models for other medical centers and a foundation for extending and expanding support to retired physicians.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 179-186"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145238851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Mediterranean Lifestyle and Lower Risk of Chronic Kidney Disease: A Population-Based Prospective Study 地中海式生活方式与慢性肾脏疾病风险降低之间的关系:一项基于人群的前瞻性研究
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.05.031
Hyo Jeong Kim MD , Hee Byung Koh MD , Chan-Young Jung MD, PhD , Hyung Woo Kim MD , Jung Tak Park MD, PhD , Tae Ik Chang MD, PhD , Tae-Hyun Yoo MD, PhD , Shin-Wook Kang MD, PhD , Seung Hyeok Han MD, PhD

Objective

To investigate the association between the Mediterranean lifestyle and incident chronic kidney disease (CKD).

Patients and Methods

This population-based, prospective, observational study used data from the UK Biobank cohort, collected from March 13, 2006, through July 31, 2010, and included 158,080 participants without CKD who completed a dietary assessment. The main predictor was the Mediterranean Lifestyle (MEDLIFE) index, comprising 3 blocks: (1) Mediterranean food consumption, (2) Mediterranean dietary habits, and (3) physical activity, rest, social habits, and conviviality. A Cox proportional hazards model was used to investigate the association between the MEDLIFE index and incident CKD. Further analysis was conducted to examine the associations between the individual blocks and items of the MEDLIFE index and the incidence of CKD.

Results

At baseline, individuals with a higher MEDLIFE index score had lower blood pressure and body mass index and were less likely to have diabetes, hypertension, or cardiovascular disease. During median follow-up of 11.2 years, CKD occurred in 4354 participants (2.75%). The adjusted hazard ratio per 1-point increase in the MEDLIFE index for incident CKD was 0.94 (95% CI, 0.93 to 0.96). Compared with quartile 1 of the MEDLIFE index, the adjusted hazard ratios (95% CIs) for quartiles 2 to 4 were 0.80 (0.74 to 0.87), 0.76 (0.70 to 0.82), and 0.65 (0.59 to 0.72), respectively. This favorable association was consistently observed for all 3 blocks of the MEDLIFE index.

Conclusion

These results suggest that a higher MEDLIFE index is associated with a lower risk of incident CKD.
目的:探讨地中海式生活方式与慢性肾脏疾病(CKD)发生的关系。患者和方法:这项基于人群的前瞻性观察性研究使用了2006年3月13日至2010年7月31日收集的英国生物银行队列数据,包括158,080名无CKD的参与者,他们完成了饮食评估。主要预测指标是地中海生活方式(MEDLIFE)指数,包括3个部分:(1)地中海食物消费,(2)地中海饮食习惯,(3)身体活动、休息、社交习惯和娱乐。采用Cox比例风险模型研究MEDLIFE指数与CKD发生率之间的关系。进一步分析MEDLIFE指数的各个区块和项目与CKD发病率之间的关系。结果:基线时,MEDLIFE指数得分较高的个体血压和体重指数较低,患糖尿病、高血压或心血管疾病的可能性较小。在11.2年的中位随访期间,有4354名参与者(2.75%)发生CKD。MEDLIFE指数每增加1个点,CKD事件的调整风险比为0.94 (95% CI, 0.93至0.96)。与MEDLIFE指数的四分位数1相比,四分位数2 ~ 4的校正风险比(95% ci)分别为0.80(0.74 ~ 0.87)、0.76(0.70 ~ 0.82)和0.65(0.59 ~ 0.72)。在MEDLIFE指数的所有3个区块中都一致观察到这种有利的关联。结论:这些结果表明,较高的MEDLIFE指数与较低的CKD发生风险相关。
{"title":"Association Between Mediterranean Lifestyle and Lower Risk of Chronic Kidney Disease: A Population-Based Prospective Study","authors":"Hyo Jeong Kim MD ,&nbsp;Hee Byung Koh MD ,&nbsp;Chan-Young Jung MD, PhD ,&nbsp;Hyung Woo Kim MD ,&nbsp;Jung Tak Park MD, PhD ,&nbsp;Tae Ik Chang MD, PhD ,&nbsp;Tae-Hyun Yoo MD, PhD ,&nbsp;Shin-Wook Kang MD, PhD ,&nbsp;Seung Hyeok Han MD, PhD","doi":"10.1016/j.mayocp.2025.05.031","DOIUrl":"10.1016/j.mayocp.2025.05.031","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the association between the Mediterranean lifestyle and incident chronic kidney disease (CKD).</div></div><div><h3>Patients and Methods</h3><div>This population-based, prospective, observational study used data from the UK Biobank cohort, collected from March 13, 2006, through July 31, 2010, and included 158,080 participants without CKD who completed a dietary assessment. The main predictor was the Mediterranean Lifestyle (MEDLIFE) index, comprising 3 blocks: (1) Mediterranean food consumption, (2) Mediterranean dietary habits, and (3) physical activity, rest, social habits, and conviviality. A Cox proportional hazards model was used to investigate the association between the MEDLIFE index and incident CKD. Further analysis was conducted to examine the associations between the individual blocks and items of the MEDLIFE index and the incidence of CKD.</div></div><div><h3>Results</h3><div>At baseline, individuals with a higher MEDLIFE index score had lower blood pressure and body mass index and were less likely to have diabetes, hypertension, or cardiovascular disease. During median follow-up of 11.2 years, CKD occurred in 4354 participants (2.75%). The adjusted hazard ratio per 1-point increase in the MEDLIFE index for incident CKD was 0.94 (95% CI, 0.93 to 0.96). Compared with quartile 1 of the MEDLIFE index, the adjusted hazard ratios (95% CIs) for quartiles 2 to 4 were 0.80 (0.74 to 0.87), 0.76 (0.70 to 0.82), and 0.65 (0.59 to 0.72), respectively. This favorable association was consistently observed for all 3 blocks of the MEDLIFE index.</div></div><div><h3>Conclusion</h3><div>These results suggest that a higher MEDLIFE index is associated with a lower risk of incident CKD.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 49-62"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145313296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
65-Year-Old Man With Oral Ulcers 65岁男子口腔溃疡。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2024.11.038
Trenton R. Madison MD , Carlie A. Aurubin MD, PhD , Dacre R.T. Knight MD
{"title":"65-Year-Old Man With Oral Ulcers","authors":"Trenton R. Madison MD ,&nbsp;Carlie A. Aurubin MD, PhD ,&nbsp;Dacre R.T. Knight MD","doi":"10.1016/j.mayocp.2024.11.038","DOIUrl":"10.1016/j.mayocp.2024.11.038","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 173-178"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Control of Metabolic Factors in the Psoriasis–Psoriatic Arthritis Transition 银屑病-银屑病关节炎转变过程中代谢因子的控制
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.11.006
Enrique R. Soriano MD, MSC
{"title":"Control of Metabolic Factors in the Psoriasis–Psoriatic Arthritis Transition","authors":"Enrique R. Soriano MD, MSC","doi":"10.1016/j.mayocp.2025.11.006","DOIUrl":"10.1016/j.mayocp.2025.11.006","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 12-14"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy 肥厚性心肌病基因变异携带者的心血管健康和预后
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2024.12.018
Nirav Patel MD, MSPH , Mokshad Gaonkar MS , Akhil Pampana MS , Jasninder S. Dhaliwal MD , Nehal Vekariya MS , Naman S. Shetty MD , Peng Li PhD , Rajat Kalra MBChB, MS , Garima Arora MD , Pankaj Arora MD

Objective

To elucidate the interplay between genetic predisposition and cardiovascular health (CVH) factors in individuals with pathogenic or likely pathogenic variants in hypertrophic cardiomyopathy sarcomere-encoding genes (SARC-HCM-P/LP).

Methods

This retrospective cohort study used data from the UK Biobank, including 159,375 participants aged 40 to 69 years with whole exome sequencing data and no baseline cardiovascular disease. Participants were stratified into 2 groups based on the presence of SARC-HCM-P/LP variants (SARC-HCM-P/LP vs SARC-NEG). Cardiovascular health was assessed by the Life’s Essential 8 score, categorizing participants into favorable, intermediate, and unfavorable CVH profiles. The primary outcome was a composite of heart failure, arrhythmias, and cardiovascular mortality. Adjusted Cox models examined the association between genetic variant status, CVH, and risk of adverse cardiovascular outcomes.

Results

Of 159,375 participants, 446 were SARC-HCM-P/LP carriers (median age, 56 years; 47.3% male). The median Life’s Essential 8 score was similar between SARC-HCM-P/LP and SARC-NEG groups (68.1 vs 66.9; P=.36). Compared with SARC-NEG carriers with favorable CVH, the risk of the primary outcome was higher in SARC-NEG carriers with intermediate (adjusted hazard ratio [HRadj), 1.14; 95% CI, 1.10 to 1.18) and unfavorable (HRadj, 1.52; 95% CI, 1.47 to 1.58) CVH profiles. Importantly, SARC-HCM-P/LP carriers, regardless of CVH profile, had a significantly higher risk of the primary outcome with favorable (HRadj, 2.12; 95% CI, 1.45 to 3.09), intermediate (HRadj, 2.19; 95% CI, 1.51 to 3.18), and unfavorable (HRadj, 2.30; 95% CI, 1.65 to 3.19) profiles.

Conclusion

SARC-HCM-P/LP carriers remain at elevated cardiovascular risk despite favorable CVH, highlighting the significant role of genetics in this population.
目的:探讨肥厚性心肌病肌节编码基因(SARC-HCM-P/LP)致病性或可能致病性变异个体的遗传易感性与心血管健康(CVH)因素之间的相互作用。方法:这项回顾性队列研究使用来自英国生物银行的数据,包括159,375名年龄在40至69岁之间的参与者,具有全外显子组测序数据,无基线心血管疾病。根据是否存在SARC-HCM-P/LP变异,将参与者分为两组(SARC-HCM-P/LP vs SARC-NEG)。心血管健康通过生命基本8分进行评估,将参与者分为有利、中等和不利的CVH概况。主要结局是心力衰竭、心律失常和心血管死亡率的综合结果。调整后的Cox模型检验了遗传变异状态、CVH和不良心血管结局风险之间的关系。结果:159,375名参与者中,446名为SARC-HCM-P/LP携带者(中位年龄56岁;47.3%的男性)。SARC-HCM-P/LP组和SARC-NEG组的中位Life's Essential 8评分相似(68.1 vs 66.9;P = 36)。与CVH有利的SARC-NEG携带者相比,SARC-NEG携带者发生主要结局的风险较高,为中等(校正风险比[HRadj], 1.14;95% CI, 1.10 ~ 1.18)和不利(HRadj, 1.52;95% CI, 1.47 - 1.58) CVH谱。重要的是,无论CVH情况如何,SARC-HCM-P/LP携带者的主要结局为有利(HRadj, 2.12;95% CI, 1.45 ~ 3.09),中级(HRadj, 2.19;95% CI, 1.51 ~ 3.18)和不利(HRadj, 2.30;95% CI, 1.65 ~ 3.19)。结论:尽管CVH有利,但SARC-HCM-P/LP携带者仍有较高的心血管风险,突出了遗传在该人群中的重要作用。
{"title":"Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy","authors":"Nirav Patel MD, MSPH ,&nbsp;Mokshad Gaonkar MS ,&nbsp;Akhil Pampana MS ,&nbsp;Jasninder S. Dhaliwal MD ,&nbsp;Nehal Vekariya MS ,&nbsp;Naman S. Shetty MD ,&nbsp;Peng Li PhD ,&nbsp;Rajat Kalra MBChB, MS ,&nbsp;Garima Arora MD ,&nbsp;Pankaj Arora MD","doi":"10.1016/j.mayocp.2024.12.018","DOIUrl":"10.1016/j.mayocp.2024.12.018","url":null,"abstract":"<div><h3>Objective</h3><div>To elucidate the interplay between genetic predisposition and cardiovascular health (CVH) factors in individuals with pathogenic or likely pathogenic variants in hypertrophic cardiomyopathy sarcomere-encoding genes (SARC-HCM-P/LP).</div></div><div><h3>Methods</h3><div>This retrospective cohort study used data from the UK Biobank, including 159,375 participants aged 40 to 69 years with whole exome sequencing data and no baseline cardiovascular disease. Participants were stratified into 2 groups based on the presence of SARC-HCM-P/LP variants (SARC-HCM-P/LP vs SARC-NEG). Cardiovascular health was assessed by the Life’s Essential 8 score, categorizing participants into favorable, intermediate, and unfavorable CVH profiles. The primary outcome was a composite of heart failure, arrhythmias, and cardiovascular mortality. Adjusted Cox models examined the association between genetic variant status, CVH, and risk of adverse cardiovascular outcomes.</div></div><div><h3>Results</h3><div>Of 159,375 participants, 446 were SARC-HCM-P/LP carriers (median age, 56 years; 47.3% male). The median Life’s Essential 8 score was similar between SARC-HCM-P/LP and SARC-NEG groups (68.1 vs 66.9; <em>P</em>=.36). Compared with SARC-NEG carriers with favorable CVH, the risk of the primary outcome was higher in SARC-NEG carriers with intermediate (adjusted hazard ratio [HR<sub>adj</sub>), 1.14; 95% CI, 1.10 to 1.18) and unfavorable (HR<sub>adj</sub>, 1.52; 95% CI, 1.47 to 1.58) CVH profiles. Importantly, SARC-HCM-P/LP carriers, regardless of CVH profile, had a significantly higher risk of the primary outcome with favorable (HR<sub>adj</sub>, 2.12; 95% CI, 1.45 to 3.09), intermediate (HR<sub>adj</sub>, 2.19; 95% CI, 1.51 to 3.18), and unfavorable (HR<sub>adj</sub>, 2.30; 95% CI, 1.65 to 3.19) profiles.</div></div><div><h3>Conclusion</h3><div>SARC-HCM-P/LP carriers remain at elevated cardiovascular risk despite favorable CVH, highlighting the significant role of genetics in this population.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 73-84"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144698980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
23-Year-Old Man With Isolated Thrombocytopenia 23岁男性孤立性血小板减少症。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2024.11.035
Sanjna Rajput MD , Mason J. Webb MD, PhD , Carrie A. Thompson MD
{"title":"23-Year-Old Man With Isolated Thrombocytopenia","authors":"Sanjna Rajput MD ,&nbsp;Mason J. Webb MD, PhD ,&nbsp;Carrie A. Thompson MD","doi":"10.1016/j.mayocp.2024.11.035","DOIUrl":"10.1016/j.mayocp.2024.11.035","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 156-161"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply: Comments on “Maternal Sepsis: Review and Update” 回复:关于“产妇败血症:回顾与更新”的评论。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.1016/j.mayocp.2025.09.007
Fadi B. Yahya MD, MHA, Amy L. Van Abel PharmD, RPh, BCPS
{"title":"In Reply: Comments on “Maternal Sepsis: Review and Update”","authors":"Fadi B. Yahya MD, MHA,&nbsp;Amy L. Van Abel PharmD, RPh, BCPS","doi":"10.1016/j.mayocp.2025.09.007","DOIUrl":"10.1016/j.mayocp.2025.09.007","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 1","pages":"Pages 196-199"},"PeriodicalIF":6.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145678023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mayo Clinic proceedings
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1